DSpace at RU >

Search Results

Results 1-18 of 18.

Item hits:

Full Text	Issue Date	Title	Author(s)
	2011	A novel hemostasis assay for the simultaneous measurement of coagulation and fibrinolysis.	Geffen, M. van; Loof, A.H.; Lap, P.; Boezeman, J.B.M.; Laros-van Gorkom, B.A.P.; Brons, P.; Verbruggen, B.; Kraaij, M.G.J. van; Heerde, W.L. van
	2011	The factor VIII inhibitor assays can be standardized: results of a workshop	Verbruggen, H.W.; Dardikh, M.; Polenewen, R.; Duren, C. van; Meijer, P.
	2010	Non-parallelism in the one-stage coagulation factor assay is a phenomenon of lupus anticoagulants and not of individual factor inhibitors.	Ruinemans-Koerts, J.; Peterse-Stienissen, I.T.A.; Verbruggen, B.
	2010	Diagnosis and quantification of factor VIII inhibitors.	Verbruggen, B.
	2010	Haemophilia A and von Willebrand's disease.	Goodeve, A.C.; Rosen, S.; Verbruggen, B.
	2010	Thrombocytopenia in early malaria is associated with GP1b shedding in absence of systemic platelet activation and consumptive coagulopathy.	Mast, Q. de; Groot, P.G. de; Heerde, W.L. van; Roestenberg, M.; Velzen, J.F. van; Verbruggen, B.; Roest, M.; McCall, M.B.B.; Nieman, A.E.; Westendorp, J.; Syafruddin, D.; Fijnheer, R.; Dongen-Lases, E.C. van; Sauerwein, R.W.; Ven, A.J.A.M. van der
	2009	Misleading one-stage coagulation factor assay during rFVIIa treatment in lupus patient.	Herbers, A.H.E.; Verbruggen, H.W.; Veerdonk, F.L. van de; Kraaij, M.G.J. van; Blijlevens, N.M.A.; Novakova, I.R.O.
	2009	Use of the platelet function analyzer to minimize bleeding complications after renal biopsy.	Hoogen, M.W.F. van den; Verbruggen, H.W.; Polenewen, R.; Hilbrands, L.B.; Novakova, I.R.O.
	2008	Diagnosis of factor VIII deficiency.	Verbruggen, B.; Meijer, P.; Novakova, I.; Heerde, W. Van
	2007	Methodological shortcomings in assessment of factor VIII concentrate inhibition.	Verbruggen, B.; Heerde, W.L. van; Budde, U.
	2006	Relatie tussen het genotype en het risico op inhibitorvorming bij patienten met hemofilie A.	Heerde, W.L. van; Boekhorst, J.; Novakova, I.R.O.; Kraaij, M.G.J. van; Verbruggen, B.
	2006	A model for the harmonisation of test results of different quantitative D-dimer methods.	Meijer, P.; Haverkate, F.; Kluft, C.; Moerloose, P. de; Verbruggen, B.; Spannagl, M.
	2005	Thirteen novel mutations in the factor VIII gene in the Nijmegen haemophilia A patient population.	Boekhorst, J.; Verbruggen, B.; Lavergne, J.M.; Costa, J.M.; Schoormans, S.C.M.; Brons, P.P.T.; Kraaij, M.G.J. van; Nováková, I.R.O.; Heerde, W.L. van
	1997	D-Dimer determination to assess regression of deep venous thrombosis	Janssen, M.C.H.; Verbruggen, H.W.; Wollersheim, H.C.H.; Hoogkamer, B.; Langen, H. van; Nováková, I.R.O.
	1997	D-Dimer determination to assess regression of deep venous thrombosis	Janssen, M.C.H.; Verbruggen, H.W.; Wollersheim, H.C.H.; Hoogkamer, B.; Langen, H. van; Nováková, I.R.O.
	1997	Reliability of five rapid D-dimer assays compared to ELISA in the exclusion of deep veneous thrombosis	Janssen, M.C.H.; Heebels, A.E.; Metz, M. de; Verbruggen, H.W.; Wollersheim, H.C.H.; Janssen, S.; Schuurmans, M.M.J.; Nováková, I.R.O.
	1995	The Nijmegen Modification of the Bethesda Assay for factor VIII:C inhibitors : improved specificity and reliability	Verbruggen, H.W.; Nováková, I.R.O.; Wessels, J.M.C.; Boezeman, J.B.M.; Berg, M. van den; Mauser-Bunschoten, E.
	1995	Semi-automated detection of the factor V mutation by allele specific amplification and capillary electrophoresis	Locht, A.T.F. van de; Kuypers, A.W.H.M.; Verbruggen, H.W.; Linssen, P.C.M.; Nováková, I.R.O.; Mensink, E.J.B.M.

1